Home/Acticor Biotech/Yannick Pletan
YP

Yannick Pletan

Chief Financial Officer

Acticor Biotech

Therapeutic Areas

Acticor Biotech Pipeline

DrugIndicationPhase
Glenzocimab (ACT017)Acute Ischemic StrokePhase 2/3